Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Sun, Jin"'
Autor:
In Gyu Hwang, Sang-Cheol Lee, Yaewon Yang, Sung Yong Oh, Sang-Gon Park, So Yeon Jeon, Dae Young Zang, Jung Hun Kang, Jun Ho Ji, Hyun Woo Lee, Woo Kyun Bae, Sun Jin Sym, Se-Il Go, Joung Soon Jang, Jung Hoon Kim
Publikováno v:
European Journal of Cancer. 157:21-30
Background The efficacy of modified FOLFIRINOX (mFOLFIRINOX) as a second-line chemotherapy treatment for metastatic pancreatic adenocarcinoma (mPAC), remains unclear. This multi-center randomised phase III trial aimed to elucidate the efficacy of mFO
Autor:
Philip J. Gold, Jan K Davidson-Moncada, Keun-Wook Lee, Yeul Hong Kim, Jon M. Wigginton, Minori Koshiji Rosales, Se Hoon Park, Rosalyn A. Juergens, Haeseong Park, Hope E. Uronis, Cheng Ean Chee, Yee Chao, Daniel V.T. Catenacci, Aleksandra Franovic, Yoon-Koo Kang, Jeffrey L. Nordstrom, Kristen A. Marrone, Eun-Kee Song, Jill Lacy, Sunnie Kim, Johanna C. Bendell, Sang Cheul Oh, Matthew C.H. Ng, Ronan J. Kelly, Jennifer Yen, Jong Gwang Kim, Keith L. Knutson, Yung-Jue Bang, A. Craig Lockhart, Howard S. Hochster, Daner Li, Thierry Alcindor, Sun Jin Sym, Peter C. Enzinger
Publikováno v:
The Lancet Oncology. 21:1066-1076
Summary Background Margetuximab, a novel, investigational, Fc-engineered, anti-HER2 monoclonal antibody, is designed to more effectively potentiate innate immunity than trastuzumab. We aimed to evaluate the safety, tolerability, and antitumour activi
Autor:
Yoon-Koo Kang, Li-Tzong Chen, Min-Hee Ryu, Do-Youn Oh, Sang Cheul Oh, Hyun Cheol Chung, Keun-Wook Lee, Takeshi Omori, Kohei Shitara, Shinichi Sakuramoto, Ik-Joo Chung, Kensei Yamaguchi, Ken Kato, Sun Jin Sym, Shigenori Kadowaki, Kunihiro Tsuji, Jen-Shi Chen, Li-Yuan Bai, Sung-Yong Oh, Yasuhiro Choda, Hisateru Yasui, Kentaro Takeuchi, Yoshinori Hirashima, Shunsuke Hagihara, Narikazu Boku
Publikováno v:
The Lancet. Oncology. 23(2)
The additive or synergistic sustained antitumour effect of immune checkpoint inhibitors in combination with oxaliplatin-based chemotherapy has previously been reported. We investigated the efficacy of nivolumab plus oxaliplatin-based chemotherapy ver
Autor:
Junshik Hong, Sun Jin Sym, Inkeun Park, Jinny Park, Jae Hoon Lee, Dong Bok Shin, Young Saing Kim, Hee Kyung Ahn, Seung Joon Choi, Yong Ju Shin, Eun Kyung Cho
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The aim of this study was to verify prognostic factors including sarcopenia in patients with recurrent or metastatic pancreatic cancer receiving gemcitabine-based chemotherapy. Materials and Methods Medical records and computed tomography sca
Autor:
Chang Woo Kim, Gyung Mo Son, Suk-Hwan Lee, Ki Beom Bae, Seung Hyuk Baik, Sun Jin Park, Byung Noe Bae, Byung Mo Kang, Won Cheol Park, Seong Kyu Baek, Yoon-Suk Lee, Ji-Yeon Kim, Ik Yong Kim
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision (TME) has been a standard treatment option for locally advanced rectal cancer with improved local control. However, systemic recurrence despite neoadjuvant CRT remained unchang
Autor:
In Gyu Hwang, Eun Kee Song, Samyong Kim, Sun Jin Sym, Sung Hyun Yang, Chi Hoon Maeng, Dae Young Zang, Moon Hee Lee, Sun Young Rha, Myounghee Kang, Do Youn Oh, Nam-Su Lee, Byoung Yong Shim, Ki Hyang Kim, Jin Ho Baek, Minkyu Jung, Yeul Hong Kim, Keun Wook Lee, Hong Suk Song, Hyun Woo Lee, Dong Hoe Koo, Jae Yong Cho, Jin Soo Kim, Kyoung Eun Lee, Young Seon Hong, Min Hee Ryu, Dae Ro Choi, Young Lee Park, Hye Sook Han, Yoon-Koo Kang
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 21(5)
Ramucirumab improves survival in gastric cancer patients. The efficacy and safety of ramucirumab outside of a clinical trial were evaluated using an expanded access program (EAP). Advanced gastric cancer patients treated with ramucirumab in combinati
Autor:
Jeong Eun Kim, Yong Sang Hong, Young Suk Park, Dong Bok Shin, Jin Seok Ahn, Kyu Pyo Kim, Jae-Lyun Lee, Tae Won Kim, Seong Joon Park, Jeeyun Lee, Sun Jin Sym
Publikováno v:
Supportive Care in Cancer. 23:1769-1777
The granisetron transdermal system (GTS) showed non-inferior efficacy to oral granisetron to control chemotherapy-induced nausea and vomiting (CINV) during multiday chemotherapy. We compared the efficacy and safety of GTS with that of intravenous and
Autor:
Sun Young Kyung, Hee Kyung Ahn, Dong Bok Shin, Sun Jin Sym, Eun Kyung Cho, Jeong-Woong Park, Sung Hwan Jeong, Minkyu Jung, Shin Myung Kang
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Genexol-PM is a Cremorphor EL (CrEL)-free polymeric micelle formulation of paclitaxel that allows higher-dose administration with less hypersensitivity. This study was designed to evaluate the efficacy and safety of Genexol-PM and gemcitabine
Autor:
Sun Jin Sym, Jinny Park, Se Hoon Park, Eun Kyung Cho, Min Chung, Junshik Hong, Woon Ki Lee, Hee Kyung Ahn, Inkeun Park, Jae Hoon Lee, Dong Bok Shin, Young Saing Kim
Publikováno v:
Cancer Chemotherapy and Pharmacology. 73:163-169
Docetaxel, in combination with cisplatin or oxaliplatin, has demonstrated efficacy in advanced gastric cancer (AGC). This randomized, non-comparative phase II trial evaluated two weekly docetaxel-based regimens to determine which is the most promisin
Autor:
Kyu-Pyo Kim, Jae-Gook Shin, Tae Won Kim, Jae-Lyun Lee, Ho-Sook Kim, Jung Shin Lee, Sun Jin Sym, Yong Sang Hong, Yoon-Koo Kang, Kyun-Seop Bae, Heung-Moon Chang
Publikováno v:
Cancer Chemotherapy and Pharmacology. 71:1609-1617
UGT1A1 genotypes are important when considering treatment with irinotecan-containing regimens. In this study, we determined the dose, efficacy, and tolerability of irinotecan according to UGT1A1 genotypes when combined with capecitabine in patients w